Skip to main content

Table 5 Characterization of HCC cases

From: IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals

Character HCC group
(N=50)
PVT 11 (22%)
Extrahepatic, LN spread 7 (14%)
Median period between EOT and HCC 18 m ± 6 m
Number of focal lesions
 Single 23 (46%)
 2–3 12 (24%)
 > 3 15 (30%)
BCLC
 Very early, early (0,A) 12 (24%)
 Intermediate (B) 16 (32%)
 Advanced (C) 4 (8%)
 Terminal (D) 18 (36%)